Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.

Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J.

J Natl Cancer Inst. 2009 Jan 21;101(2):88-99. doi: 10.1093/jnci/djn444. Epub 2009 Jan 13.

PMID:
19141778
2.

The role of breast FNAC in diagnosis and clinical management: a survey of current practice.

Kocjan G, Bourgain C, Fassina A, Hagmar B, Herbert A, Kapila K, Kardum-Skelin I, Kloboves-Prevodnik V, Krishnamurthy S, Koutselini H, Majak B, Olszewski W, Onal B, Pohar-Marinsek Z, Shabalova I, Smith J, Tani E, Vielh P, Wiener H, Schenck U, Schmitt F.

Cytopathology. 2008 Oct;19(5):271-8. doi: 10.1111/j.1365-2303.2008.00610.x. Review.

PMID:
18821945
3.

A randomized trial of basing treatment on human papillomavirus and/or cytology results in low-grade cervical lesion triage.

Bjerre P, Silfverdal L, Dillner L, Hagmar B, Edvardsson H, Dillner J, Andersson-Ellström A.

Am J Obstet Gynecol. 2008 Jul;199(1):24.e1-7. doi: 10.1016/j.ajog.2007.11.053. Epub 2008 Mar 4.

PMID:
18295172
4.

[What is the optimal age to start cervix screening?].

Steen R, Hagen B, Hagmar B, Iversen OE, Juvkam KH, Thoresen S, Hareide B, Skjeldestad FE.

Tidsskr Nor Laegeforen. 2008 Jan 31;128(3):339. Norwegian. No abstract available.

5.

p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas.

O'Regan EM, Toner ME, Finn SP, Fan CY, Ring M, Hagmar B, Timon C, Smyth P, Cahill S, Flavin R, Sheils OM, O'Leary JJ.

Hum Pathol. 2008 Mar;39(3):452-8. doi: 10.1016/j.humpath.2007.08.004.

PMID:
18261630
6.

Expression of p16INK4a and MIB-1 in relation to histopathology and HPV types in cervical adenocarcinoma.

Muller S, Flores-Staino C, Skyldberg B, Hellström AC, Johansson B, Hagmar B, Wallin KL, Andersson S.

Int J Oncol. 2008 Feb;32(2):333-40.

PMID:
18202755
7.

p16(INK4a) immunocytochemistry in liquid-based cervical cytology: is it feasible for clinical use?

Norman I, Brismar S, Zhu J, Gaberi V, Hagmar B, Hjerpe A, Andersson S.

Int J Oncol. 2007 Dec;31(6):1339-43.

PMID:
17982660
8.

[HPV test makes cytological examination more accurate. Cervical cancer can be discovered more efficiently].

Andersson S, Hjerpe A, Johansson BC, Hagmar B.

Lakartidningen. 2007 Sep 26-Oct 2;104(39):2797-9. Review. Swedish. No abstract available.

PMID:
17958005
9.

The future of cytopathology in Europe. Will the wider use of HPV testing have an impact on the provision of cervical screening?

Gray W, Bayer-Pietsch E, Chieco P, Cochand Priollet B, Desai M, Drijkoningen M, Griffin M, Hagmar B, Kapila K, Kloboves-Prevodnik V, Kobayashi T, Krogerus L, Majak B, Mihailovici M, Olszewski W, Schenck U, Schmitt F, Shabalova I, Shapiro N, Smith J, Tani E, Totsch M, Vass L, Wiener H, Herbert A.

Cytopathology. 2007 Oct;18(5):278-82. Review.

PMID:
17883689
10.

[Are analyses of cytological cervix smears from young women more harmful than beneficial?].

Skjeldestad FE, Hagen B, Hagmar B, Iversen OE, Juvkam KH, Steen R, Thoresen S, Hareide B.

Tidsskr Nor Laegeforen. 2007 Jun 28;127(13):1782-5. Norwegian.

11.

A comparison of liquid-based cytology and Pap smear as a screening method for cervical cancer.

Zhu J, Norman I, Elfgren K, Gaberi V, Hagmar B, Hjerpe A, Andersson S.

Oncol Rep. 2007 Jul;18(1):157-60.

PMID:
17549362
12.

Expression of p16(INK4a) in relation to histopathology and viral load of 'high-risk' HPV types in cervical neoplastic lesions.

Andersson S, Wangsa D, Flores-Staino C, Safari H, Mints M, Hjerpe A, Hagmar B, Johansson B.

Eur J Cancer. 2006 Nov;42(16):2815-20. Epub 2006 Sep 14.

PMID:
16973350
13.

Fine needle aspiration cytology: a survey of current European practice.

Kocjan G, Feichter G, Hagmar B, Kapila K, Kardum-Skelin I, Kloboves V, Kobayashi TK, Koutselini H, Majak B, Schenck U, Schmitt F, Tani E, Totch M, Onal B, Vass L, Vielh P, Weynand B, Herbert A.

Cytopathology. 2006 Oct;17(5):219-26.

PMID:
16961648
14.

Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age.

Molden T, Kraus I, Karlsen F, Skomedal H, Hagmar B.

Gynecol Oncol. 2006 Jan;100(1):95-100. Epub 2005 Sep 8.

PMID:
16153696
15.
16.

Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.

Molden T, Nygård JF, Kraus I, Karlsen F, Nygård M, Skare GB, Skomedal H, Thoresen SO, Hagmar B.

Int J Cancer. 2005 May 10;114(6):973-6.

17.
18.

Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia.

Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Lie K, Barrera-Saldana HA, Wiley DJ, Bernard HU.

J Virol. 2004 Dec;78(23):12762-72.

19.

Cytopathology in Norway.

Hagmar B, Bofin A, Berner A, Sauer T.

Cytopathology. 2004 Oct;15(5):283-5. Review. No abstract available.

PMID:
15456417
20.
21.

Detection and quantitation of HER-2 gene amplification and protein expression in breast carcinoma.

Bofin AM, Ytterhus B, Martin C, O'Leary JJ, Hagmar BM.

Am J Clin Pathol. 2004 Jul;122(1):110-9.

PMID:
15272539
22.

Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones.

Kraus I, Molden T, Ernø LE, Skomedal H, Karlsen F, Hagmar B.

Br J Cancer. 2004 Apr 5;90(7):1407-13.

23.

Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants.

Calleja-Macias IE, Kalantari M, Huh J, Ortiz-Lopez R, Rojas-Martinez A, Gonzalez-Guerrero JF, Williamson AL, Hagmar B, Wiley DJ, Villarreal L, Bernard HU, Barrera-Saldaña HA.

Virology. 2004 Feb 20;319(2):315-23.

24.

TOP2A and HER-2 gene amplification in fine needle aspirates from breast carcinomas.

Bofin AM, Ytterhus B, Hagmar BM.

Cytopathology. 2003 Dec;14(6):314-9.

PMID:
14632728
25.
26.

Ki-67 antigen detection in unstained and destained cytologic samples.

Nordgård S, Bofin A, Hagmar B.

Anal Quant Cytol Histol. 2002 Aug;24(4):198-204.

PMID:
12199320
27.

Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom.

Scott DR, Hagmar B, Maddox P, Hjerpe A, Dillner J, Cuzick J, Sherman ME, Stoler MH, Kurman RJ, Kiviat NB, Manos MM, Schiffman M.

Cancer. 2002 Feb 25;96(1):14-20.

28.

[Can human papillomavirus testing and vaccination prevent cervical cancer?].

Lie AK, Bjørge T, Helland A, Hagen B, Skjeldestad FE, Hagmar B, Thoresen S.

Tidsskr Nor Laegeforen. 2001 Oct 20;121(25):2947-51. Review. Norwegian.

PMID:
11715778
29.

Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas.

Kalantari M, Blennow E, Hagmar B, Johansson B.

Diagn Mol Pathol. 2001 Mar;10(1):46-54.

PMID:
11277395
30.

A population-based five-year follow-up study of cervical human papillomavirus infection.

Elfgren K, Kalantari M, Moberger B, Hagmar B, Dillner J.

Am J Obstet Gynecol. 2000 Sep;183(3):561-7.

PMID:
10992174
31.

The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.

Andersson-Ellström A, Seidal T, Grannas M, Hagmar B.

Acta Obstet Gynecol Scand. 2000 Mar;79(3):221-6.

PMID:
10716304
32.

Fine needle aspiration biopsy in selecting treatment for inconclusive intraocular disease.

Eide N, Syrdalen P, Walaas L, Hagmar B.

Acta Ophthalmol Scand. 1999 Aug;77(4):448-52.

33.

High risk genital papillomavirus infections are not spread vertically.

Dillner J, Andersson-Ellström A, Hagmar B, Schiller J.

Rev Med Virol. 1999 Jan-Mar;9(1):23-9. Review.

PMID:
10371669
34.

Low detection rate of HPV in oral and laryngeal carcinomas.

Matzow T, Boysen M, Kalantari M, Johansson B, Hagmar B.

Acta Oncol. 1998;37(1):73-6.

PMID:
9572657
35.

Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis.

Kalantari M, Karlsen F, Kristensen G, Holm R, Hagmar B, Johansson B.

Int J Gynecol Pathol. 1998 Apr;17(2):146-53.

PMID:
9553812
36.

Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade: a study on 476 Stockholm women, using PCR for detection and typing of HPV.

Kalantari M, Karlsen F, Johansson B, Sigurjonsson T, Wärleby B, Hagmar B.

Hum Pathol. 1997 Aug;28(8):899-904.

PMID:
9269825
37.

[Sexuality and STD infections among teenage girls. "Unprotected sex" is common in spite of sufficient knowledge about the risks].

Andersson-Ellström A, Dillner J, Hagmar B, Milsom I.

Lakartidningen. 1997 Feb 19;94(8):619-21. Swedish.

PMID:
9072650
38.

Use of multiple PCR primer sets for optimal detection of human papillomavirus.

Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, Johansson B, Hagmar B.

J Clin Microbiol. 1996 Sep;34(9):2095-100.

39.

Human papillomavirus deoxyribonucleic acid in cervix only detected in girls after coitus.

Andersson-Ellström A, Hagmar BM, Johansson B, Kalantari M, Wärleby B, Forssman L.

Int J STD AIDS. 1996 Aug-Sep;7(5):333-6.

PMID:
8894822
40.

HLA DQ-DR haplotype and susceptibility to cervical carcinoma: indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18.

Allen M, Kalantari M, Ylitalo N, Pettersson B, Hagmar B, Scheibenpflug L, Johansson B, Petterson U, Gyllensten U.

Tissue Antigens. 1996 Jul;48(1):32-7.

PMID:
8864172
41.
42.

Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study.

Andersson-Ellström A, Dillner J, Hagmar B, Schiller J, Sapp M, Forssman L, Milsom I.

Sex Transm Dis. 1996 May-Jun;23(3):234-8.

PMID:
8724515
44.

Implications of human papillomavirus type for survival in cervical squamous cell carcinoma.

Hagmar B, Christensen JJ, Johansson B, Kalantari M, Ryd W, Skyldberg B, Walaas L, Wärleby B, Kristensen GB.

Int J Gynecol Cancer. 1995 Sep;5(5):341-345.

PMID:
11578501
45.

Assessment of fine needle aspiration cytology and histopathology for diagnosing male breast masses.

Lilleng R, Paksoy N, Vural G, Langmark F, Hagmar B.

Acta Cytol. 1995 Sep-Oct;39(5):877-81.

PMID:
7571963
46.

Human papillomavirus in cell samples from Stockholm Gynecologic Health Screening.

Hagmar B, Kalantari M, Skyldberg B, Moberger B, Johansson B, Walaas L, Wärleby B.

Acta Cytol. 1995 Jul-Aug;39(4):741-5.

PMID:
7631548
47.

Inflammatory signs in wet smear and Pap-smear compared with the histopathology from the female lower genital tract.

Vural G, Platz-Christensen JJ, Hagmar B, Jonassen F, Warleby B, Andersson E.

Acta Obstet Gynecol Scand. 1995 Jul;74(6):451-4.

PMID:
7604689
48.

HPV detection in cytological cases with condylomatous or dysplastic changes: a study with PCR and in situ hybridization on cytological material.

Skyldberg B, Hagmar B, Johansson B, Kalantari M, Moberger B, Walaas L, Wärleby B.

Diagn Cytopathol. 1995 Jul;13(1):8-14.

PMID:
7587882
49.

Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.

Heino P, Skyldberg B, Lehtinen M, Rantala I, Hagmar B, Kreider JW, Kirnbauer R, Dillner J.

J Gen Virol. 1995 May;76 ( Pt 5):1141-53.

PMID:
7537325
50.

No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients.

Kristensen GB, Kaern J, Abeler VM, Hagmar B, Tropé CG, Pettersen EO.

Gynecol Oncol. 1995 Apr;57(1):79-85.

PMID:
7705705

Supplemental Content

Loading ...
Support Center